Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.205 USD | -2.64% | -14.03% | -26.67% |
Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.67% | 1.74B | |
-3.34% | 102B | |
+1.75% | 96.07B | |
-1.80% | 21.66B | |
-17.88% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.01% | 13.79B | |
-0.65% | 13.33B | |
+19.22% | 10.94B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Insider Sell: Recursion Pharmaceuticals